Preparation method of sensor chip for detecting chronic kidney disease markers creatinine and uric acid in saliva
By preparing hollow PBAs@PPy materials and combining them with a three-enzyme method, a sensor chip was designed to solve the problems of inconvenient sampling and detection difficulty in detecting creatinine and uric acid in saliva, achieving high sensitivity and rapid non-invasive diagnostic results.
Patent Information
- Application Number
- CN202411333380.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-24
- Publication Date
- 2024-11-26
AI Technical Summary
Existing technologies for detecting creatinine and uric acid in saliva suffer from problems such as inconvenient sampling, high detection difficulty, and poor specificity, which affect the accuracy of non-invasive diagnosis of chronic kidney disease.
Hollow-structured PBAs@PPy materials were prepared using soluble manganese salts, ferricyanide salts, and pyrrole monomers. A sensor chip with a hollow structure was designed by combining the three-enzyme method and the chronoamperometry method. The H2O2 generated by the reaction of enzymes with substrates was utilized, and the changes in current signals were used to detect creatinine and uric acid.
It achieves high sensitivity and rapid detection, with detection times of 30 seconds for creatinine and 5 seconds for uric acid, exhibiting excellent selectivity and sensitivity, thus increasing the possibility of non-invasive diagnosis of chronic kidney disease.
Smart Images

Figure CN119023760A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of clinical biosensor diagnosis, and relates to a method for preparing a sensor chip for detecting creatinine and uric acid, markers of chronic kidney disease in saliva. Background Art
[0002] Chronic kidney disease is a progressive disease characterized by changes in the structure and function of the kidneys due to various causes. Around the world, more and more patients are affected by chronic kidney disease. Approximately 10% of adults worldwide are affected by chronic kidney disease, resulting in 1.2 million deaths and 280 million lives lost each year. It is expected that by 2040, chronic kidney disease will become the fifth leading cause of death worldwide.
[0003] At present, the international guidelines define the disease standard of chronic kidney disease as a glomerular filtration rate (GFR) less than 60 ml / min, or abnormal levels of kidney damage markers. Biomarkers of chronic kidney disease include creatinine, potassium, urea, uric acid, etc. Serum creatinine is the gold standard for diagnosing chronic kidney disease. Creatinine is a muscle metabolic waste product. After entering the blood, it is filtered by the kidneys and excreted from the body through urine. If kidney function is abnormal, the serum creatinine level will increase. Although serum creatinine is the main indicator reflecting kidney function, it also has limitations. For example, people with normal kidney function may also show elevated serum creatinine levels. Therefore, it is necessary to combine creatinine with multiple markers to improve diagnostic accuracy. Uric acid is the final product of human purine metabolism. About 70% of uric acid is metabolized by the kidneys every day. A decrease in GFR can lead to changes in serum uric acid levels. Therefore, it is scientifically based to use creatinine and uric acid as detection markers for chronic kidney disease.
[0004] However, routine clinical analysis of biomarkers of chronic kidney disease requires the extraction of serum samples, which still has limitations in terms of convenience, comfort and safety of sampling. In recent years, non-invasive testing based on saliva has received increasing attention due to its advantages such as convenient, safe and painless sampling. Many analytes in saliva, including creatinine and uric acid, have been shown to be highly correlated with serum levels. Therefore, the detection of creatinine and uric acid in saliva can be used as an effective means of non-invasive diagnosis of chronic kidney disease. However, the concentration of each analyte in saliva is significantly lower than that in serum, which increases the difficulty of detection. In addition, there are a large number of complex substances in saliva, which puts higher requirements on the specificity of detection. Summary of the invention
[0005] Aiming at the problems existing in the traditional detection of creatinine and uric acid in saliva, the present invention proposes a novel method for preparing a sensor chip for detecting creatinine and uric acid, which are markers of chronic kidney disease in saliva.
[0006] In order to achieve the above object, the present invention is implemented by adopting the following technical solutions: A method for preparing a sensor chip for detecting creatinine and uric acid, markers of chronic kidney disease in saliva, comprises the following steps.
[0007] (1) Add soluble manganese salt and surfactant into water and mix them evenly, add soluble ferrocyanide salt and mix them evenly to obtain a suspension mixture, let it stand for aging at room temperature, and then centrifuge and dry it to obtain a MnFe PBA material.
[0008] (2) Add MnFe PBA material into water, mix well, then add excess FeCl3, stir and mix once to obtain mixed solution A, add Py monomer under continuous stirring to obtain reaction solution, carry out polymerization reaction, centrifuge and dry after the reaction to obtain hollow PBAs@PPy material.
[0009] (3) Conductive ink was used as a dual working electrode and a counter electrode, and silver chloride was used as a reference electrode. A sensor chip with dual working electrodes was prepared by screen printing. The hollow PBAs@PPy material was added into water and mixed evenly to obtain a dispersion B. The dispersion B was dripped onto the first working electrode and the second working electrode respectively. Then, a mixture C of creatinase, creatinase and sarcosinase was dripped onto the first working electrode, dried at low temperature, and then a layer of curing agent was dripped and dried at low temperature. A mixture D of uricase and chitosan was dripped onto the second working electrode and dried at low temperature. A dual-electrode detection sensor chip for creatinine and uric acid was obtained.
[0010] Preferably, in step (1), the soluble manganese salt is any one of manganese chloride, manganese sulfate or manganese nitrate, the soluble ferrocyanide salt is potassium ferrocyanide or sodium ferrocyanide, and the molar concentrations of the manganese salt and the ferrocyanide salt in the suspension mixture are both 5-30 mM; the static aging time is 12-24 h, the drying temperature is 55-65°C, and the drying time is 12-24 h.
[0011] Preferably, in step (2), the concentration of MnFe PBA material in the mixed solution A is 1-3 mg / ml, the mass ratio of MnFe PBA material to FeCl3 is 1:10-30, the concentration of Py monomer in the reaction solution is 1.5 mM, the polymerization reaction time is 2-6 h, the drying temperature is 55-65°C, and the drying time is 12-24 h.
[0012] Preferably, in step (3), the concentration of PBAs@PPy material in dispersion B is 2-5 mg / ml, the mixed solution C is a mixture of equal volumes of creatinase aqueous solution, creatinase aqueous solution and sarcosinase aqueous solution with a concentration of 5-10 U / μl, the curing agent is glutaraldehyde aqueous solution, and the mass fraction of glutaraldehyde aqueous solution is 2-3%; the concentration of uricase in mixed solution D is 2-5 U / μl, and the concentration of chitosan is 2-5 mg / ml; and the low-temperature drying temperature is 4°C.
[0013] The present invention proposes the use of the sensor chip prepared by the above method in a non-invasive salivary marker diagnosis product for chronic kidney disease patients.
[0014] The present invention adds the oxidant FeCl3 to the precursor MnFe PBA, and the two react. 3+ It will preferentially react with [Fe(CN)4] 2- PB is generated, and MnFe PBA will partially dissolve to form a hollow or semi-hollow PB and MnFe PBA complex. If Py monomer is added, it will immediately polymerize with FeCl3 in the solution to generate a PPy shell. 2+ Will replace Mn in MnFe PBA 2+ , generating PB, the semi-hollow PBAs become completely hollow, and finally forming PBAs@PPy with a hollow structure. The core of the complex is PB, which can highly sensitively identify H2O2 produced by the reaction of enzyme and substrate, and the outer shell is a conductive polymer PPy, which can improve the catalytic performance while reducing the interference of small molecules in saliva, such as ascorbic acid. In addition, the hollow structure can significantly improve the conductivity of the material. The present invention uses a chronoamperometry to detect creatinine and uric acid, wherein a three-enzyme method (creatinase, creatinase, sarcosinase) is used to detect creatinine, and glutaraldehyde is used to fix the three enzymes; uricase is used to detect uric acid, and chitosan is used to fix it. The reaction of the three enzymes with creatinine and the reaction of uricase with uric acid at different potentials will produce H2O2, PB efficiently recognizes H2O2 to produce electrons, so that the current signal increases, and by analyzing the relationship between the change in the current and the concentration of creatinine or uric acid, a linear regression curve or equation can be obtained, thereby realizing the specific detection of creatinine or uric acid.
[0015] Compared with the prior art, the advantages and positive effects of the present invention are: 1. In the present invention, the oxidant FeCl3 and the Py monomer are added to the precursor MnFe PBA respectively to obtain PBAs@PPy with a hollow structure, and the preparation process is simple and reliable.
[0016] 2. According to the characteristic that enzymes react with substrates to generate H2O2, the present invention designs PB as the reaction active center. The outer layer of PPy improves the conductivity of the material while effectively preventing small molecules from entering the active center, thereby increasing the specificity of the sensor.
[0017] 3. The sensor designed by the present invention has high sensitivity and fast detection time. The sensitivity to creatinine and uric acid is 9.98 μA / (mM cm 2 ) and 144.9 μA / (mM cm 2) detection times are 30 s and 5 s respectively, and the excellent selectivity provides new possibilities for non-invasive diagnosis of chronic kidney disease. BRIEF DESCRIPTION OF THE DRAWINGS
[0018] Figure 1 This is the SEM image of MnFe PBA.
[0019] Figure 2 TEM image of hollow PBAs@PPy.
[0020] Figure 3 Schematic diagram of screen-printed chip. DETAILED DESCRIPTION
[0021] In order to more clearly understand the above-mentioned purpose, features and advantages of the present invention, the present invention is further described below in conjunction with specific embodiments. It should be noted that the embodiments of the present application and the features in the embodiments can be combined with each other without conflict.
[0022] In the following description, many specific details are set forth to facilitate a full understanding of the present invention. However, the present invention may also be implemented in other ways than those described herein. Therefore, the present invention is not limited to the specific embodiments of the following disclosure.
[0023] Example 1 (1) Preparation of MnFe PBA materials Prepare 100 ml of 20 mM manganese sulfate solution, add 0.2 g polyvinyl pyrrolidone, and sonicate for 10 minutes. Prepare 100 ml of 20 mM potassium ferrocyanide solution, sonicate for 10 minutes, pour into the manganese sulfate solution, and age for 12 hours, then centrifuge at 8000 r / min for 5 minutes. Then put it in an oven and dry it at 60°C to obtain MnFe PBA material. SEM characterization was performed to observe its microscopic morphology, and the results are as follows: Figure 1 As shown, from Figure 1 The MnFe PBA in the sample has a regular cubic structure with uniform size of about 1 μm.
[0024] (2) Preparation of hollow PBAs@PPy materials The prepared MnFe PBA was added to deionized water to prepare a 50 ml mixed solution with a concentration of 1 mg / ml, and then 1 g FeCl3 was added. The mixture was stirred at 500 rpm for 12 h at room temperature. Then 50 μl Py monomer was added and the mixture was stirred at 500 rpm for 3 h at room temperature. The mixture was then centrifuged at 8000 r / min for 5 min and placed in an oven for drying at 60°C to obtain a hollow PBAs@PPy material. The TEM image is shown in Fig. Figure 2 .from Figure 2 It can be seen that the material has an obvious hollow structure, in which the hollow framework is composed of PB and a layer of PPy is wrapped outside the framework. In addition, a small amount of MnFe PBA may exist outside the structure.
[0025] (3) Preparation of creatinine and uric acid sensor chip According to Figure 3 The dual working electrode microchip was prepared in the pattern shown, in which the conductive carbon paste (purchased from Shenzhen Jieyongcheng Technology Co., Ltd., model JC-42102) was printed on the two working electrodes and the counter electrode area, and the silver / silver chloride paste (purchased from Julong Huina Electronic Technology Co., Ltd., model JYS600) was printed on the reference electrode area, and the sensor chip was printed through the designed screen. The two working electrodes were recorded as the first working electrode and the second working electrode respectively. PBAs@PPy was added to deionized water and mixed evenly to prepare a suspension with a concentration of 3 mg / ml. 3 μl of each was dropped on the two working electrodes of the screen-printed chip and dried at room temperature for 2 h. Equal volumes of 10 U / μl creatinase aqueous solution, 10 U / μl creatinase aqueous solution and 5 U / μl creatinase aqueous solution were mixed, and 3 μl was dropped on the first working electrode, dried at 4°C for 12 h, and then 1 μl of 2.5% glutaraldehyde solution was dropped, and dried at 4°C for 1 h to obtain the creatinine chip working electrode. An equal volume of 2.5 U / μl uricase solution and 3 mg / ml chitosan solution were mixed, and 3 μl of the mixture was dropped on the second working electrode. After drying at 4°C for 12 h, the uric acid chip working electrode was obtained.
[0026] The performance of the prepared sensor microchip for creatinine and uric acid was tested by the chronoamperometry of Shanghai Chenhua CHI660E electrochemical workstation. Specifically, the chip was inserted into the electrode head, and the three lines on the electrode head representing the working electrode, the counter electrode and the reference electrode were connected to the corresponding electrode lines on the electrochemical workstation respectively. The working voltage of the creatinine chip is -0.4V, and the working voltage of the uric acid chip is 0.3 V. When detecting creatinine, a working voltage of -0.4V is applied, and the uric acid sensor on the working electrode 2 does not react; similarly, when detecting uric acid, a working voltage of 0.3 V is applied, and the creatinine sensor on the working electrode 1 does not react. By adding different concentrations of creatinine and lactic acid from low to high, the tests were carried out separately, and different current responses were obtained. The detection limit of the obtained biosensor for creatinine is 0.05 mM, the linear range is 0.05-1.05 mM, and the sensitivity is 9.98 μA / (mM cm 2 ), the detection time is only 30 s. Through analysis, the change of current is linearly related to the creatinine concentration, and the equation is y=-0.00365+0.705x, r 2=0.999, where y is the current change and x is the creatinine concentration (mM). The detection limit for uric acid is 0.005 mM, the linear range is 0.005-2.33 mM, and the sensitivity is 144.9 μA / (mMcm 2 ), the detection time is only 5 s. Through analysis, the change of current is linearly related to the uric acid concentration, and the equation is y=0.157+10.24x, r 2 =0.993, where y is the current change and x is the uric acid concentration (mM).
[0027] To verify the accuracy of the prepared sensor microchip and its reliability in the diagnosis of chronic kidney disease markers, it was applied to artificial saliva and real saliva for detection, and the results were compared with those of high performance liquid chromatography (HPLC).
[0028] 1. Artificial saliva testing In order to verify the accuracy of the PBAs@PPy chip prepared in this example, artificial saliva (purchased from Aladdin) containing known concentrations of creatinine / uric acid was used for detection.
[0029] The prepared artificial saliva stock solution was divided into 3 groups, and different amounts of creatinine and uric acid were added to prepare artificial saliva samples with creatinine concentrations of 0.05 mM, 0.1 mM, and 1 mM, and uric acid concentrations of 0.005 mM, 0.1 mM, and 1 mM, respectively. The prepared samples were divided into 6 parts, and the PB / AuNG microchip prepared in this embodiment and high performance liquid chromatography (HPLC) were used for testing. Each concentration was tested 3 times and the average was taken. The test results are shown in Table 1. The relative error of the test results of the PBAs@PPy chip prepared in this embodiment is within 5%, indicating that the chip prepared by the present invention has a high accuracy. In addition, the sensor microchip prepared by the present invention has an advantage in detection time. The microchip prepared in this embodiment can obtain the test results within 30 s, while HPLC requires more than 30 min.
[0030] Table 1 Test results of artificial saliva by PBAs@PPy chip and HPLC 2. Real saliva test In order to verify the feasibility and applicability of the PBAs@PPy chip prepared in this example in real saliva, saliva of 2 healthy people (serial numbers 1-2) and 3 patients with chronic nephritis (serial numbers 3-5) was collected in this example (sample source: Nanjing Stomatological Hospital), and the saliva was tested by the sensor microchip and HPLC, respectively. The results are shown in Table 2. It can be seen that the sensor microchip prepared in the present invention has similar test results to HPLC.
[0031] Table 2 Example 1 Test results of PBAs@PPy chip and HPLC on real saliva Example 2 The present embodiment is consistent with the embodiment 1 unless otherwise specified.
[0032] (1) Preparation of MnFe PBA materials Prepare 100 ml of 20 mM manganese sulfate solution, add 0.2 g polyvinyl pyrrolidone, and ultrasonicate for 10 min. Prepare 100 ml of 20 mM potassium ferrocyanide solution, ultrasonicate for 10 min, pour into the manganese sulfate solution, statically age for 12 h, and centrifuge at 8000 r / min for 5 min. Then put it in an oven and dry it at 60°C to obtain MnFe PBA material.
[0033] (2) Preparation of hollow PBAs@PPy materials The prepared MnFe PBA was added to deionized water and mixed evenly to prepare a 50 ml solution with a concentration of 1 mg / ml. Subsequently, 0.5 g FeCl3 was added and stirred at 500 rpm for 12 h. Then, 50 μl Py monomer was added and reacted at 500 rpm for 3 h at room temperature. Then, the mixture was centrifuged at 8000 r / min for 5 min and placed in an oven and dried at 60°C for 12 h to obtain a hollow PBAs@PPy material.
[0034] (3) Preparation of creatinine and uric acid sensor chip PBAs@PPy was added to deionized water and mixed evenly to obtain a dispersion with a concentration of 3 mg / ml. 3 μl of each dispersion was dripped on the two working electrodes of the screen-printed chip and dried at room temperature for 2 h. 10 U / μl creatinase aqueous solution, 10 U / μl creatinase aqueous solution and 5 U / μl sarcosinase aqueous solution were mixed in equal volumes, 3 μl was dripped on the first working electrode, and 1 μl of 2% glutaraldehyde solution was dripped and dried at 4°C for 1 h to obtain the creatinine chip working electrode. 2.5 U / μl uricase solution and 3 mg / ml chitosan solution were mixed in equal volumes, 3 μl of the mixture was dripped on the second working electrode, and the uric acid chip working electrode was obtained after drying at 4°C for 12 h.
[0035] The biosensor prepared in this embodiment has a detection range of 0.05-1.05 mM for creatinine and a sensitivity of 9.21 μA / (mM cm 2 ), the detection time is 30 s; the detection range of uric acid is 0.005-2.33 mM, and the sensitivity is 140.2 μA / (mM cm 2), the detection time is 5 s.
[0036] Example 3 The present embodiment is consistent with the embodiment 1 unless otherwise specified.
[0037] (1) Preparation of MnFe PBA materials Prepare 100 ml of 20 mM manganese sulfate solution, add 0.2 g polyvinyl pyrrolidone, and ultrasonicate for 10 min. Prepare 100 ml of 20 mM potassium ferrocyanide solution, ultrasonicate for 10 min, pour into the manganese sulfate solution, statically age for 12 h, and centrifuge at 8000 r / min for 5 min. Then put it in an oven and dry it at 60°C to obtain MnFe PBA material.
[0038] (2) Preparation of hollow PBAs@PPy materials The prepared MnFe PBA was added to deionized water and mixed evenly to prepare 50 ml of a dispersion with a concentration of 1 mg / ml. Subsequently, 1.5 g of FeCl3 was added and stirred at 500 rpm for 12 h. Then, 50 μl of Py monomer was added and reacted at room temperature at 500 rpm for 3 h. The mixture was then centrifuged at 8000 r / min for 5 min and placed in an oven and dried at 60°C for 12 h to obtain a hollow PBAs@PPy material.
[0039] (3) Preparation of creatinine and uric acid sensor chip PBAs@PPy was added to deionized water and mixed evenly to obtain a dispersion with a concentration of 3 mg / ml. 3 μl of each dispersion was dripped on the two working electrodes of the screen-printed chip and dried at room temperature for 2 h. 10 U / μl creatinase aqueous solution, 10 U / μl creatinase aqueous solution and 5 U / μl sarcosinase aqueous solution were mixed in equal volumes, 3 μl was dripped on the first working electrode, and 1 μl of 3% glutaraldehyde solution was dripped and dried at 4°C for 1 h to obtain the creatinine chip working electrode. 2.5 U / μl uricase solution and 3 mg / ml chitosan solution were mixed in equal volumes, 3 μl of the mixture was dripped on the second working electrode, and the uric acid chip working electrode was obtained after drying at 4°C for 12 h.
[0040] The detection range of the biosensor prepared in this embodiment for creatinine is 0.05-1.05 mM, and the sensitivity is 9.38 μA / (mM cm 2 ), the detection time is 30 s; the detection range of uric acid is 0.005-2.33 mM, and the sensitivity is 142.7 μA / (mM cm 2 ), the detection time is 5 s.
[0041] Comparative Example 1 The difference between this comparative example and Example 1 is that the amount of FeCl3 added in step (2) is 0.1 g, and the other conditions are consistent with Example 1.
[0042] The obtained biosensor has a detection range of 0.01-0.32 mM for creatinine and a sensitivity of 1.89 μA / (mMcm 2 ), the detection time is 120 s; the detection range of uric acid is 0.01-0.8 mM, and the sensitivity is 25.6 μA / (mM cm 2 ), and the detection time is 20 s. Through this comparative example, it is found that a small amount of FeCl3 cannot generate a hollow structure, resulting in a decrease in the conductivity and catalytic performance of the material, which ultimately significantly affects the performance of the sensor, increases the detection time, and narrows the detection range.
[0043] Comparative Example 2 The difference between this comparative example and Example 1 is that in step (3), the creatininase is 4 U / μl, the creatinase is 4 U / μl, the sarcosinase is 2 U / μl, and the uricase is 1 U / μl, and the other conditions are the same as those in Example 1.
[0044] The obtained biosensor has a detection range of 0.02-0.36 mM for creatinine and a sensitivity of 2.25 μA / (mMcm 2 ), the detection time was 150 s, the detection range of uric acid was 0.01-0.34 mM, and the sensitivity was 35.2 μA / (mM cm 2 ), and the detection time is 25 s. This comparative example shows that the enzyme concentration is an important factor affecting the performance of the sensor. A small amount of enzyme reduces the catalytic rate of the substrate, cannot produce enough signals for the reduced substrate, and cannot completely catalyze the substrate with a higher concentration, thereby increasing the detection time, narrowing the detection range, and reducing the sensitivity.
[0045] Comparative Example 3 The difference between this comparative example and Example 1 is that in step (3), the concentration of the chitosan solution is 10 mg / ml, the mass fraction of the glutaraldehyde solution is 10%, and the other conditions are consistent with those in Example 1.
[0046] The obtained biosensor has a detection range of 0.01-0.26 mM for creatinine and a sensitivity of 1.47 μA / (mMcm 2 ), the detection time was 165 s, the detection range of uric acid was 0.008-0.42 mM, and the sensitivity was 22.4 μA / (mM cm 2), the detection time is 25 s. It can be seen from this comparative example that the concentration of the immobilized enzyme solution has an important influence on the performance of the sensor. Chitosan and glutaraldehyde are both non-conductive molecules. The increase in their concentrations will hinder the reaction between the substrate and the enzyme, which is not conducive to electron transfer, and ultimately lead to an increase in detection time, a narrow detection range, and a decrease in sensitivity.
[0047] Comparative Example 4 The difference between this comparative example and Example 1 is that in step (3), uricase is dripped onto the working electrode 1, and after drying, 1 μl of a 2.5% by mass glutaraldehyde solution is dripped to obtain a uric acid chip, and 3 μl of an equal volume mixture of creatinase, creatinase, sarcosinase and 3 mg / ml chitosan is dripped onto the working electrode 2, and after drying, a creatinine chip is obtained. The other conditions are the same as those in Example 1.
[0048] The obtained biosensor has a detection range of 0.008-0.19 mM for creatinine and a sensitivity of 3.46 μA / (mMcm 2 ), the detection time was 180 s, the detection range of uric acid was 0.012-0.64 mM, and the sensitivity was 32.1 μA / (mM cm 2 ), the detection time is 20 s. It can be seen from this comparative example that the enzyme fixation method has an important influence on the performance of the sensor. In the present invention, the three-enzyme method is selected to detect creatinine. The performance of the creatinine sensor is greatly affected by the reaction of three enzymes with three substrates. When a certain reaction is affected, the next reaction will also be implicated. When the three enzymes are mixed with chitosan, the reactions of the three enzymes are hindered, resulting in a longer detection time. Therefore, it can be seen from this comparative example that chitosan is more suitable for the fixation of uricase.
[0049] The above description is only a preferred embodiment of the present invention and does not limit the present invention in other forms. Any technician familiar with the profession may use the technical content disclosed above to change or modify it into an equivalent embodiment with equivalent changes and apply it to other fields. However, any simple modification, equivalent change and modification made to the above embodiment based on the technical essence of the present invention without departing from the content of the technical solution of the present invention still falls within the protection scope of the technical solution of the present invention.
Claims
1. A method for preparing a sensor chip for detecting creatinine and uric acid, markers of chronic kidney disease in saliva. It is characterized in that Here are the steps: (1) adding a soluble manganese salt and a surfactant into water, mixing them evenly, adding a soluble ferrocyanide salt, mixing them evenly to obtain a suspension mixture, allowing it to stand for aging at room temperature, and then centrifuging and drying it to obtain a MnFe PBA material; (2) Add MnFe PBA material to water, mix well and then add excess FeCl 3 After stirring and mixing once, a mixed solution A is obtained, and Py monomer is added under continuous stirring to obtain a reaction solution, and a polymerization reaction is carried out. After the reaction is completed, the mixture is centrifuged and dried to obtain a hollow PBAs@PPy material; (3) Conductive ink was used as a dual working electrode and a counter electrode, and silver chloride was used as a reference electrode. A sensor chip with dual working electrodes was prepared by screen printing. The hollow PBAs@PPy material was added into water and mixed evenly to obtain a dispersion B. The dispersion B was dripped onto the first working electrode and the second working electrode respectively. Then, a mixture C of creatinase, creatinase and sarcosinase was dripped onto the first working electrode, dried at low temperature, and then a layer of curing agent was dripped and dried at low temperature. A mixture D of uricase and chitosan was dripped onto the second working electrode and dried at low temperature. A dual-electrode detection sensor chip for creatinine and uric acid was obtained.
2. The method for preparing a sensor chip for detecting creatinine and uric acid, markers of chronic kidney disease in saliva, according to claim 1, It is characterized in that In step (1), the soluble manganese salt is any one of manganese chloride, manganese sulfate or manganese nitrate, the soluble ferrocyanide salt is potassium ferrocyanide or sodium ferrocyanide, and the molar concentrations of the manganese salt and the ferrocyanide salt in the suspension mixture are both 5-30 mM; the static aging time is 12-24 h, the drying temperature is 55-65° C., and the drying time is 12-24 h.
3. The method for preparing a sensor chip for detecting creatinine and uric acid, markers of chronic kidney disease in saliva, according to claim 1, It is characterized in that Step (2) The concentration of MnFe PBA material in the mixed solution A is 1-3 mg / ml. 3 The mass ratio of is 1:10-30, the concentration of Py monomer in the reaction solution is 1.5 mM, the polymerization reaction time is 2-6 h, the drying temperature is 55-65°C, and the drying time is 12-24 h.
4. The method for preparing a sensor chip for detecting creatinine and uric acid, markers of chronic kidney disease in saliva, according to claim 1, It is characterized in that In step (3), the concentration of PBAs@PPy material in dispersion B is 2-5 mg / ml, the mixed solution C is a mixture of equal volumes of creatinase aqueous solution, creatinase aqueous solution and sarcosinase aqueous solution with a concentration of 5-10 U / μl, the curing agent is glutaraldehyde aqueous solution, and the mass fraction of glutaraldehyde aqueous solution is 2-3%; the concentration of uricase in mixed solution D is 2-5 U / μl, and the concentration of chitosan is 2-5 mg / ml; the low-temperature drying temperature is 4°C.
5. Use of the sensor chip prepared by the method according to any one of claims 1 to 4 in a non-invasive salivary marker diagnosis product for chronic kidney disease patients.
